secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2026-02-11T23:59:59+00:00
Accession:  0001609550-26-000012
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Q4 rev $269M (+12%), EPS $4.66; FY26 outlook lowered on coding change
-----------------------------------------------------------------------------

- Q4 revenue $269.1M (+12%); GAAP diluted EPS $4.66; adjusted EPS $1.65.
- Full year revenue $912M (+14%); operating cash flow $117M; share repurchases $175M.
- FY2026 revenue guidance revised to $950M-$1.0B (4-10% growth); adjusted EPS $1.85-$2.35.
- Inspire V procedure coding changed to CPT 64582 with -52 modifier, reducing physician fees; company disappointed.
- Board proposes declassification and removal of for-cause removal; effective upon shareholder approval at 2026 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955026000012/0001609550-26-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955026000012/insp-20260205.htm
  HTML page:      https://secwatch.observer/filing/0001609550-26-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer